The largest database of trusted experimental protocols

10 protocols using ionomycin iono

1

Th0, Th1, and Th17 Cell Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Th0 conditions, sorted naïve CD4+ T cells were stimulated (day 0) with plate-bound anti-CD3ε (1 μg/ml; BD Biosciences) and anti-CD28 (3 μg/ml; BD Biosciences) on 48-well-plates (0.3 × 106 cells/well) in 1 ml T cell medium/well (RPMI1640 supplemented with 10% FBS [Sigma/biowest], antibiotics, 50 mM β-mercaptoethanol) supplemented with 20 U/ml recombinant human IL-2 (rhIL-2) (Peprotech) for 3 days, unless otherwise stated. For the assessment of cell proliferation, 1–10 × 106 naïve CD4+ T cells were labeled using Cell Proliferation Dye eFluor™ 450 (Thermo Scientific) according to the manufacturer's protocol prior to activation. Th1 and Th17 cells were generated from sorted naïve CD4+ T cells activated with anti-CD3ε/anti-CD28 for 3 days in the presence of 20 U/ml rhIL-2 (Peprotech), 5 ng/ml IL-12 (R&D Systems) and 3 μg/ml anti-IL-4 (BioXcell) for Th1 cells, and in the presence of 2 ng/ml TGFβ, 10 μg/ml IL-6, 10 μg/ml IL-1α, and 10 μg/ml IL-1β for Th17 cells. For cytokine detection, activated cells were restimulated for 4 h with phorbol 12-myristate 13-acetate (PMA, 25 ng/ml) and ionomycin (Iono, 750 ng/ml) (both from Sigma-Aldrich) in the presence of GolgiStop (BD Biosciences).
+ Open protocol
+ Expand
2

Stimulation and Analysis of Immune Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole PBMC were left untreated or stimulated with 100 ng/ml staphylococcal enterotoxin B (SEB, Sigma) at 2*10e6 cells per ml for 18 h at 37 °C. Supernatants were harvested and stored at −80 °C until use. CD4+, CD8+, CD14+, CD19+, CD56+ sorted cells, and moDCs were either left untreated or stimulated at 2*10e6 cells per ml with 100 ng/ml SEB, 1 μg/ml resiquimod (R848) (InvivoGen)—a toll-like receptor 7 and 8 ligand, a potent activator of both monocytes and B cells—, 10 μ/ml CD3/28 beads (Gibco, Life Technologies) for 18 h or 100 ng/ml phorbol myristate acetate (PMA, Sigma) and 1 μg/ml ionomycin (iono, Sigma) for 6 h at 37 °C.
For mRNA analysis, cells were lysed with RLT Plus buffer (Qiagen) and kept at −20 °C until further extraction.
+ Open protocol
+ Expand
3

Analyzing CAR T Cell Functionality

Check if the same lab product or an alternative is used in the 5 most similar protocols
Degranulation, measured by cell surface modulation of CD107a25 (link) and intracellular cytokine production (TNF-α and IFN-γ), was analyzed by flow cytometry of CAR T cells incubated with different target cells. Briefly, CD44v6.CAR T and CD19.CAR T cells from different donors, at day 11–15 after the initial stimulation, were left untreated or stimulated with target cells at the ratio of 1:1. Anti-CD107a Ab (Miltenyi) and monensin and brefeldin (BD Biosciences) were added during the incubation period. As positive control, CAR T cells were stimulated with 10 ng/mL phorbol myristate acetate (PMA; Sigma) and 1 μg/mL ionomycin (IONO; Sigma). After 5 h of incubation, cells were stained with anti-CD3 mAb (BD Bioscience) and Viability Stain 510 (BD Bioscience), fixed, permeabilized (Cytofix/Cytoperm kit, following the manufacturer's instruction; BD Bioscience), and then stained for intracellular cytokines with TNF-α- and IFN-γ (BD Bioscience)-specific Abs. Cells were analyzed by flow cytometry, and viable CD3+/CD4+ or CD3+/CD8+ cells were analyzed for CD107a, TNF-α, and IFN-γ expression. The percentage of positive CAR T cells incubated alone (always <5%) was subtracted to the percentage of positive CAR T cells stimulated with the different targets or PMA/IONO.
+ Open protocol
+ Expand
4

PBMC Isolation and Cytofluorimetric Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
On day 0 and day 30, peripheral blood mononuclear cells (PBMCs) were isolated from heparinized blood samples by Ficoll-Hypaque (Eurobio, Les UlisCedex, France) density-gradient centrifugation. Mononuclear cells were resuspended in RPMI (Cambrex BioScience, Verviers, Belgium) completed with 10%heat-inactivated fetal calf serum (FCS, HyClone, South Logan, UT) and 1%glutamine (all from Euroclone, Milan, Italy), and left stimulated with 50 ng/ml Phorbol Myristate Acetate (PMA, Sigma-Aldrich, St Louis, MO), 1 µg/ml Ionomycin (Iono, Sigma-Aldrich). The stimulation was carried out at 37 °C for 5 h, in the presence of the intracellular trafficking inhibitor Brefeldin A (10 µg/ml BFA; Sigma-Aldrich), before intracellular staining and cytofluorimetric analysis.
+ Open protocol
+ Expand
5

Modulating Signaling Pathways in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
5 µM Brefeldin A (BFA, Sigma-Aldrich) was used to inhibit the secretory pathway and 100 nM Bafilomycin A1 (Baf, SCBT) was used to inhibit lysosomal degradation. To activate PKA signalling, 1 mM dbcAMP (SCBT) was used for 24 h. Wnt signalling was activated by 2 µM WAY-262611 (WAY, SCBT) for 6 h, or by inhibiting GSK-3β with 30 µM BI5521 (opnMe, Boehringer Ingelheim) for 1 h. To modulate Importin-β-dependent transport, 50 µM Ivermectin (ive, SCBT) for 6 h, 0.5 µM ionomycin (iono, Sigma-Aldrich) or 250 nM thapsigargin (thaps, SCBT) for 1 h were used.
+ Open protocol
+ Expand
6

Activation of Frozen Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liquid-nitrogen frozen PBMC from healthy donors and from T1D patients were thawed in complete RPMI medium (Gibco RPMI 1640 Medium, ThermoFisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS, Hyclone, South Logan, UT, USA), L-glutamine (2mM) (EuroClone S.p.A., MI, Italy) and 1% penicillin/streptomycin (pen/strep) (EuroClone) according to established protocols [19 (link)] and centrifuged at 1200 rpm for 5 minutes at room temperature (RT). Cells were cultured in 48 well plates (Falcon, Corning Incorporated, NY, USA), 1.5×106 cells per well in complete RPMI. Subsequently, cells were stimulated with the addition of 7.5 ng/ml phorbol-12-myristate-13-acetate (PMA) (Calbiochem, Merk, Darmstadt, Germany) and 0.8μg/ml Ionomycin (IONO) (Sigma Aldrich, Merk). The cells were incubated for three to five days at 37°C in a humidified atmosphere containing 5% CO2. At the end of the incubation period, cells were harvested from culture plates and washed by centrifugation 1200 rpm for 5 minutes in PBS at RT. Subsequently cells were stained for FACS analysis as described below.
+ Open protocol
+ Expand
7

Immune Regulation by PMA, Ionomycin, and OVA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phorbol 12-myristate 13-acetate (PMA; #P1585), ionomycin (Iono; #I0634), and OVA (#A5503) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Aluminum hydroxide (alum, #77161) was purchased from Thermo Fisher Scientific (Waltham, MA, USA) and C20 (#S6577) from Selleckchem (Houston, TX, USA). Antibodies against phospho(p)-PKCθ (#9377), p-STAT6 (#5654), STAT6 (#5397), p-NF-κB (#3033), and NFAT (#4389) were obtained from Cell Signaling Technology (Danvers, MA, USA), and anti-PKCθ (#sc-212), anti-β-actin (#sc-47778), and anti-lamin B1 (#sc-374015) antibodies from Santa Cruz Biotechnology (Dallas, TX, USA). Anti-GATA3 (#ab61052). Anti-inducible nitric oxide synthase (iNOS; #ab136918) antibodies were purchased from Abcam (Cambridge, UK).
+ Open protocol
+ Expand
8

Macrophage and T Cell Line Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
RAW 264.7 and THP-1
macrophage cells were obtained from the American Type Culture Collection
(ATCC, U.S.A.). Jurkat JE6-1 TLR 4, TLR 6, TLR 2/1, TLR 2/6 and TLR
2/1/6 were a kind gift from Peter Steinberg’s Lab (Medical
University of Vienna). Hank’s balanced salt solution (HBSS),
Dulbecco’s modified Eagle’s medium (DMEM), Roswell Park
Memorial Institute (RPMI) 1640, fetal bovine serum (FBS), phorbol
12-myristate 13-acetate (PMA) and ionomycin (iono) was purchased from
Sigma-Aldrich. Trypsin-ethylenediaminetetraacetic acid (EDTA) was
purchased from Invitrogen, U.S.A.
+ Open protocol
+ Expand
9

Cytomegalovirus-specific T Cell Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The IFNγ ELISpot assay was performed as previously described(8 (link)). T cells were plated in triplicate at 105 cells/well with 5 μM of CMV-pp65 pepmix. In all experiments, T cells were also incubated with an irrelevant pepmix, as negative control, or stimulated with 25 ng/mL of phorbol myristate acetate (PMA; Sigma-Aldrich, St Louis, MO) and 1 μg/mL of ionomycin (Iono; Sigma-Aldrich) as positive control. In selected experiments, CAR-CMV-CTLs were tested in ELISpot plates coated with both IFNγ antibody and anti-idiotype antibody (1A7) that induces cross-link of CAR molecules(11 (link)).
+ Open protocol
+ Expand
10

Tacrolimus Effects on T-cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were equally split into four parts and plated in 96-well U bottom plates in RPMI with 10% FBS (R10). Cells were cultured with 1μg/ml anti-CD3 and 1μg/ml anti-CD28, in the absence or presence of 0, 10, or 100ng/ml tacrolimus (Sigma-Aldrich, St. Louis, MO). Concentrations were chosen based on published information showing that 5–10ng/ml is regarded as the therapeutic trough concentration for usual dosing in MG patients, while 100ng/ml is approximately the peak concentration (Kanai et al., 2017 (link)). Cells were cultured for 3 or 7 days at 37°C in 5% CO2 in a humidified incubator, and 5 hours prior to harvesting the cells, PBMCs were re-stimulated with 1 μg/mL phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich) and 0.25μg/mL ionomycin (IONO, Sigma-Aldrich) in the presence of brefeldin A (BD Biosciences).Then, the phenotypic, molecular, and functional characterization of the PBMCs was performed as described below.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!